Close Menu

marketing agreement

According to Response Biomedical, the Canadian point-of-care market is expected to reach $66.2 million this year and to grow at 7 percent over the next few years.

Med BioGene's shareholders have approved the deal, which gives Precision rights to commercialize Med BioGene's gene expression-based test for early stage non-small-cell lung cancer.

Magellan anticipates marketing a family of Miacom sepsis tests in the US for research use only, while starting clinical trials in preparation of submission to the US Food and Drug Administration.

Under one deal, AstraNet will sell Norton's protein aggregation monitoring device in Europe, while under another, Advanced Scientific Technologies will sell PAM in the mid-Atlantic region.

Health Diagnostic Laboratory will offer the galectin-3 test to physicians along with its own cardiovascular tests.

IDT will produce the assays and market them through an online catalog directly to customers of Quanta.

The deal will make Ambry the preferred provider of genetic carrier screening for LABS and give LABS' customers access to Ambry's genetic screen for identifying carriers of severe and common childhood diseases.

The firms will co-develop a new tissue-based imaging and analysis solutions for protein biomarkers.

Seahorse Extracellular and Flux Analyzers provide a kinetic method of measuring mitochondrial respiration and glycolysis, the two major energy-producing pathways, in living cells in a microplate, the company said.

Shimadzu's LC and GC systems sold in the US will come with Phenomenex columns, under the terms of the deal.

Pages

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

In Nature this week: epigenetic factors that prevent healthy aging and more.